posted on 2006-12-01, 00:00authored byJames
A. Atwood, Todd Minning, Fernanda Ludolf, Arthur Nuccio, Daniel B. Weatherly, Gerardo Alvarez-Manilla, Rick Tarleton, Ron Orlando
Herein we detail the first glycoproteomic
analysis of a human pathogen. We describe an approach that enables
the identification of organelle and cell surface N-linked glycoproteins
from Trypanosoma cruzi, the causative agent of Chagas'
disease. This approach is based on a subcellular fractionation protocol
to produce fractions enriched in either organelle or plasma membrane/cytoplasmic
proteins. Through lectin affinity capture of the glycopeptides from
each subcellular fraction and stable isotope labeling of the glycan
attachment sites with H218O, we unambiguously
identified 36 glycosylation sites on 35 glycopeptides which mapped
to 29 glycoproteins. We also present the first expression evidence
for 11 T. cruzi specific glycoproteins and provide
experimental data indicating that the mucin associated surface protein
family (MASP) and dispersed gene family (DGF-1) are post-translationally
modified by N-linked glycans. Keywords: Trypanosoma
cruzi • lectin affinity • stable isotope labeling
• glycoproteomics • glycomics • PROVALT •
false discovery rate • mucin associated surface protein •
dispersed gene family